VGLL4-TEAD1 promotes vascular smooth muscle cell differentiation from human pluripotent stem cells via TET2

Alexander, 2012, Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease, Annu. Rev. Physiol., 74, 13, 10.1146/annurev-physiol-012110-142315 Wiegand, 2019, Recent advances in the applications of iPSC technology, Curr. Opin. Biotechnol., 60, 250, 10.1016/j.copbio.2019.05.011 Shen, 2021, Generation of vascular smooth muscle cells from induced pluripotent stem cells: methods, applications, and considerations, Circ. Res., 128, 670, 10.1161/CIRCRESAHA.120.318049 Klein, 2018, iPSCs-based generation of vascular cells: reprogramming approaches and applications, Cell. Mol. Life Sci., 75, 1411, 10.1007/s00018-017-2730-7 Maguire, 2017, Differentiation and application of induced pluripotent stem cell-derived vascular smooth muscle cells, Arterioscler. Thromb. Vasc. Biol., 37, 2026, 10.1161/ATVBAHA.117.309196 Liu, 2022, Updated perspectives on vascular cell specification and pluripotent stem cell-derived vascular organoids for studying vasculopathies, Cardiovasc. Res., 118, 97, 10.1093/cvr/cvaa313 Zheng, 2019, The hippo signaling pathway in development and disease, Dev. Cell, 50, 264, 10.1016/j.devcel.2019.06.003 Pagiatakis, 2017, TGFβ-TAZ/SRF signalling regulates vascular smooth muscle cell differentiation, FEBS J., 284, 1644, 10.1111/febs.14070 Manderfield, 2015, Hippo signaling is required for notch-dependent smooth muscle differentiation of neural crest, Development., 142, 2962 Wang, 2017, Yes-associated protein inhibits transcription of Myocardin and attenuates differentiation of vascular smooth muscle cell from cardiovascular progenitor cell lineage, Stem Cells (Dayton, Ohio)., 35, 351, 10.1002/stem.2484 Zhang, 2014, VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex, Cell Res., 24, 331, 10.1038/cr.2014.10 Feng, 2019, Dual function of VGLL4 in muscle regeneration, EMBO J, 38, 10.15252/embj.2018101051 Suo, 2020, VGLL4 promotes osteoblast differentiation by antagonizing TEADs-inhibited Runx2 transcription, Sci. Adv., 6, 10.1126/sciadv.aba4147 Wen, 2019, Transcription factor TEAD1 is essential for vascular development by promoting vascular smooth muscle differentiation, Cell Death Differ., 26, 2790, 10.1038/s41418-019-0335-4 Feng, 2019, Dual function of VGLL4 in muscle regeneration, EMBO J., 38, 10.15252/embj.2018101051 Liu, 2015, Epigenetic regulation of smooth muscle cell plasticity, Biochim. Biophys. Acta, 1849, 448, 10.1016/j.bbagrm.2014.06.004 Liu, 2013, Ten-eleven Translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity, Circulation., 128, 2047, 10.1161/CIRCULATIONAHA.113.002887 Pastor, 2013, TETonic shift: biological roles of TET proteins in DNA demethylation and transcription, Nat. Rev. Mol. Cell Biol., 14, 341, 10.1038/nrm3589 Rasmussen, 2016, Role of TET enzymes in DNA methylation, development, and cancer, Genes Dev., 30, 733, 10.1101/gad.276568.115 Kohli, 2013, TET enzymes, TDG and the dynamics of DNA demethylation, Nature., 502, 472, 10.1038/nature12750 Lio, 2020, TET methylcytosine oxidases: new insights from a decade of research, J. Biosci., 45, 10.1007/s12038-019-9973-4 Wu, 2022, YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis, Nat. Genet., 54, 1202, 10.1038/s41588-022-01119-7 Patsch, 2015, Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells, Nat. Cell Biol., 17, 10.1038/ncb3205 Chen, 2017, Loss of smooth muscle α-actin leads to NF-κB-dependent increased sensitivity to angiotensin II in smooth muscle cells and aortic enlargement, Circ. Res., 120, 1903, 10.1161/CIRCRESAHA.117.310563 Zhou, 2014, An emerging role for hippo-YAP signaling in cardiovascular development, J. Biomed. Res., 28, 251, 10.7555/JBR.28.20140020 Quan, 2022, YAP inhibition promotes endothelial cell differentiation from pluripotent stem cell through EC master transcription factor FLI1, J. Mol. Cell. Cardiol., 163, 81, 10.1016/j.yjmcc.2021.10.004 Wang, 2017, Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies, Nat. Protoc., 12, 88, 10.1038/nprot.2016.152 Deng, 2018, VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs, Am. J. Cancer Res., 8, 932 Jiao, 2014, A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer, Cancer Cell, 25, 166, 10.1016/j.ccr.2014.01.010 Tremblay, 2014, The hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation, Cancer Cell, 26, 273, 10.1016/j.ccr.2014.05.029 Langlois, 2014, TET2 deficiency inhibits mesoderm and hematopoietic differentiation in human embryonic stem cells, Stem Cells (Dayton, Ohio), vol. 32, 2084, 10.1002/stem.1718 Dash, 2015, Induced pluripotent stem cell-derived vascular smooth muscle cells: methods and application, Biochem. J., 465, 185, 10.1042/BJ20141078 Majesky, 2007, Developmental basis of vascular smooth muscle diversity, Arterioscler. Thromb. Vasc. Biol., 27, 1248, 10.1161/ATVBAHA.107.141069 Xie, 2011, Smooth muscle cell differentiation in vitro: models and underlying molecular mechanisms, Arterioscler. Thromb. Vasc. Biol., 31, 1485, 10.1161/ATVBAHA.110.221101 Mack, 2011, Signaling mechanisms that regulate smooth muscle cell differentiation, Arterioscler. Thromb. Vasc. Biol., 31, 1495, 10.1161/ATVBAHA.110.221135 Leeper, 2018, Non-coding RNAs: key regulators of smooth muscle cell fate in vascular disease, Cardiovasc. Res., 114, 611, 10.1093/cvr/cvx249 Pagiatakis, 2017, TGFbeta-TAZ/SRF signalling regulates vascular smooth muscle cell differentiation, FEBS J, 284, 1644, 10.1111/febs.14070 Suo, 2020, VGLL4 promotes osteoblast differentiation by antagonizing TEADs-inhibited Runx2 transcription, Sci. Adv., 6, 10.1126/sciadv.aba4147 Xue, 2019, Zebrafish vestigial like family member 4b is required for Valvulogenesis through sequestration of transcription factor myocyte enhancer factor 2c, Front Cell Dev Biol., 7, 277, 10.3389/fcell.2019.00277 Yu, 2019, VGLL4 plays a critical role in heart valve development and homeostasis, PLoS Genet., 15, 10.1371/journal.pgen.1007977 Feng, 2019, Dual function of VGLL4 in muscle regeneration, EMBO J., 38, 10.15252/embj.2018101051 Suo, 2020, VGLL4 promotes osteoblast differentiation by antagonizing TEADs-inhibited Runx2 transcription, Sci. Adv., 6, 10.1126/sciadv.aba4147 Liu, 2014, The transcription factor TEAD1 represses smooth muscle-specific gene expression by abolishing myocardin function, J. Biol. Chem., 289, 3308, 10.1074/jbc.M113.515817 Osman, 2021, YAP1/TEAD1 upregulate platelet-derived growth factor receptor beta to promote vascular smooth muscle cell proliferation and neointima formation, J. Mol. Cell. Cardiol., 156, 20, 10.1016/j.yjmcc.2021.03.005 Quan, 2022, YAP inhibition promotes endothelial cell differentiation from pluripotent stem cell through EC master transcription factor FLI1, J. Mol. Cell. Cardiol., 163, 81, 10.1016/j.yjmcc.2021.10.004 Alexander, 2012, Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease, Annu. Rev. Physiol., 74, 13, 10.1146/annurev-physiol-012110-142315 Liu, 2021, H3K4 di-methylation governs smooth muscle lineage identity and promotes vascular homeostasis by restraining plasticity, Dev. Cell, 56, 10.1016/j.devcel.2021.09.001 Ostriker, 2021, TET2 protects against vascular smooth muscle cell apoptosis and intimal thickening in transplant vasculopathy, Circulation., 144, 455, 10.1161/CIRCULATIONAHA.120.050553 Zeng, 2021, Circular RNA CircMAP3K5 acts as a MicroRNA-22-3p sponge to promote resolution of intimal hyperplasia via TET2-mediated smooth muscle cell differentiation, Circulation., 143, 354, 10.1161/CIRCULATIONAHA.120.049715 Liu, 2018, TET2: a novel epigenetic regulator and potential intervention target for atherosclerosis, DNA Cell Biol., 37, 517, 10.1089/dna.2017.4118 Pan, 2015, The TET2 interactors and their links to hematological malignancies, IUBMB Life, 67, 438, 10.1002/iub.1389 Xu, 2019, Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy, J. Clin. Invest., 129, 4316, 10.1172/JCI129317 An, 2015, Acute loss of TET function results in aggressive myeloid cancer in mice, Nat. Commun., 6, 10071, 10.1038/ncomms10071